4.5 Article

Prognostic significance of cardiac I-123-metaiodobenzylguanidine imaging in patients with reduced, mid-range, and preserved left ventricular ejection fraction admitted for acute decompensated heart failure: a prospective study in Osaka Prefectural Acute Heart Failure Registry (OPAR)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

Validation of 2-year 123I-meta-iodobenzylguanidine-based cardiac mortality risk model in chronic heart failure

Kenichi Nakajima et al.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2018)

Article Cardiac & Cardiovascular Systems

Creation of mortality risk charts using 123I meta-iodobenzylguanidine heart-to-mediastinum ratio in patients with heart failure: 2-and 5-year risk models

Kenichi Nakajima et al.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Iodine-123-metaiodobenzylguanidine imaging can predict future cardiac events in heart failure patients with preserved ejection fraction

Shigehiko Katoh et al.

ANNALS OF NUCLEAR MEDICINE (2010)

Review Cardiac & Cardiovascular Systems

The Sympathetic Nervous System in Heart Failure Physiology, Pathophysiology, and Clinical Implications

Filippos Triposkiadis et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)

Article Medicine, General & Internal

Long-term trends in the incidence of and survival with heart failure

D Levy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)